27652718|t|Randomized Trial of Long-Acting Insulin Glargine Titration Web Tool (LTHome) Versus Enhanced Usual Therapy of Glargine Titration (INNOVATE Trial)
27652718|a|Basal insulin titration in the real world is often unsuccessful. LTHome, a web tool, applies a rules engine-based algorithm providing insulin titration advice directly to the patient. This pilot, randomized trial evaluates basal insulin glargine titration by LTHome compared to enhanced usual therapy ([EUT]- diabetes education program) over 12 weeks. Important inclusion criteria: 18-75 years, type 2 diabetes, computer literacy, and HbA1c >7.0%. Trial protocol was approved by ethics board. We randomized 139 subjects. The achievement of primary composite outcome (four out of seven fasting plasma glucose [FPG] within 5-7.2 mmol/L + mean for three consecutive FPG within 5-7.2 mmol/L + no severe hypoglycemia) was 15% in LTHome versus 41% in EUT (noninferiority not met, P-value = 0.92). Other outcomes were similar between the LTHome and EUT arms: alternate composite outcome achievement (last five FPG mean within the range of 5-7.2 mmol/L + no hypoglycemia, 47% and 51%, P = 0.73); A1c reduction (-1.0% and -1.1%, P = 0.66); proportion achieving A1c â‰¤7% (14% and 20%, P = 0.36); and hypoglycemia incidence (31% and 37%, P = 0.4), respectively. Patient satisfaction score improvements were greater in LTHome versus EUT (change in fear of hypoglycemia score P = 0.04 and change in diabetes distress score P = 0.04). The mean number of additional healthcare provider visits was 0.13 for LTHome and 1.22 for EUT (P < 0.01). INNOVATE trial suggests clinical utility of LTHome compared to EUT in real-life settings. Further research is needed to evaluate the efficacy and safety of automated insulin titration algorithms.
27652718	0	16	Randomized Trial	T062	UMLS:C0206034
27652718	20	39	Long-Acting Insulin	T103	UMLS:C0304870
27652718	40	48	Glargine	T103	UMLS:C0907402
27652718	49	58	Titration	T058	UMLS:C0162621
27652718	59	67	Web Tool	T170	UMLS:C0037589
27652718	69	75	LTHome	T170	UMLS:C0037589
27652718	99	106	Therapy	T058	UMLS:C0087111
27652718	110	118	Glargine	T103	UMLS:C0907402
27652718	119	128	Titration	T058	UMLS:C0162621
27652718	130	144	INNOVATE Trial	T062	UMLS:C0008976
27652718	146	159	Basal insulin	T103	UMLS:C0650607
27652718	160	169	titration	T058	UMLS:C0162621
27652718	211	217	LTHome	T170	UMLS:C0037589
27652718	221	229	web tool	T170	UMLS:C0037589
27652718	241	246	rules	T170	UMLS:C0870077
27652718	247	269	engine-based algorithm	T170	UMLS:C0002045
27652718	280	287	insulin	T103	UMLS:C0021641
27652718	288	297	titration	T058	UMLS:C0162621
27652718	342	358	randomized trial	T062	UMLS:C0206034
27652718	359	368	evaluates	T058	UMLS:C0220825
27652718	369	382	basal insulin	T103	UMLS:C0650607
27652718	383	391	glargine	T103	UMLS:C0907402
27652718	392	401	titration	T058	UMLS:C0162621
27652718	405	411	LTHome	T170	UMLS:C0037589
27652718	439	446	therapy	T058	UMLS:C0087111
27652718	449	452	EUT	T058	UMLS:C0087111
27652718	455	481	diabetes education program	T058	UMLS:C1532353
27652718	541	556	type 2 diabetes	T038	UMLS:C0011860
27652718	558	575	computer literacy	T038	UMLS:C0009603
27652718	581	586	HbA1c	T103	UMLS:C0019018
27652718	594	599	Trial	T062	UMLS:C0008976
27652718	600	608	protocol	T170	UMLS:C1507394
27652718	642	652	randomized	T062	UMLS:C0034656
27652718	657	665	subjects	T098	UMLS:C0080105
27652718	731	759	fasting plasma glucose [FPG]	T033	UMLS:C1318375
27652718	809	812	FPG	T033	UMLS:C1318375
27652718	835	837	no	T033	UMLS:C1513916
27652718	845	857	hypoglycemia	T038	UMLS:C0020615
27652718	870	876	LTHome	T170	UMLS:C0037589
27652718	891	894	EUT	T058	UMLS:C0087111
27652718	977	983	LTHome	T170	UMLS:C0037589
27652718	988	991	EUT	T058	UMLS:C0087111
27652718	1049	1052	FPG	T033	UMLS:C1318375
27652718	1093	1095	no	T033	UMLS:C1513916
27652718	1096	1108	hypoglycemia	T038	UMLS:C0020615
27652718	1134	1137	A1c	T103	UMLS:C0019018
27652718	1198	1201	A1c	T103	UMLS:C0019018
27652718	1235	1247	hypoglycemia	T038	UMLS:C0020615
27652718	1352	1358	LTHome	T170	UMLS:C0037589
27652718	1366	1369	EUT	T058	UMLS:C0087111
27652718	1381	1385	fear	T038	UMLS:C0015726
27652718	1389	1401	hypoglycemia	T038	UMLS:C0020615
27652718	1431	1439	diabetes	T038	UMLS:C0011847
27652718	1440	1448	distress	T033	UMLS:C0231303
27652718	1496	1506	healthcare	T058	UMLS:C0086388
27652718	1516	1522	visits	T058	UMLS:C1512346
27652718	1536	1542	LTHome	T170	UMLS:C0037589
27652718	1556	1559	EUT	T058	UMLS:C0087111
27652718	1572	1586	INNOVATE trial	T062	UMLS:C0008976
27652718	1616	1622	LTHome	T170	UMLS:C0037589
27652718	1635	1638	EUT	T058	UMLS:C0087111
27652718	1670	1678	research	T062	UMLS:C0035168
27652718	1692	1700	evaluate	T058	UMLS:C0220825
27652718	1738	1745	insulin	T103	UMLS:C0021641
27652718	1746	1755	titration	T058	UMLS:C0162621
27652718	1756	1766	algorithms	T170	UMLS:C0002045